Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with ...

At the Kitchen & Bath Industry Show (KBIS), iSpring Water Systems showcases a range of filtration solutions designed to complement today's kitchens and lifestyles. This guide helps homeowners and ...

The family and friends of the teen whose body was found behind a South Wilkes-Barre garage last month have started a petition ...

The cobot feeder includes a storage and retrieval assembly with a UR force- and power-limited robot pedestal, enclosed steel ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...

Proteinuria affects most people with complement 3 glomerulopathy (C3G). Protein in urine is one of the strongest indicators of disease progression. Reducing proteinuria can slow the progression of C3G ...

Department of Rheumatology, Toronto University, Toronto, ON, Canada. Department of Rheumatology, Toronto University, Toronto, ON, Canada. Department of Internal Medicine, Qatif Central Hospital, Qatif ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

FDA approval enables Complement Therapeutics to start the Opti-GAIN phase 1/2 trial for CTx001 in GA secondary to AMD. CTx001 is an AAV-based gene therapy delivering a truncated Complement Receptor 1 ...

Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called "C3G" and prevent the disease progressing. Publishing in The Lancet, the ...